Recombinant Human EGFR Kinase Domain His-tag Protein, CF

R&D Systems | Catalog # 11142-ER

Analyzed by SEC-MALS
R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems Sf 21 (baculovirus)-derived Recombinant Human EGFR Kinase Domain His-tag Protein (11142-ER)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

Sf 21 (baculovirus)

Accession Number

P00533.2

Applications

Enzyme Activity
View all EGFR Proteins and Enzymes »

Product Specifications

Source

Spodoptera frugiperda, Sf 21 (baculovirus)-derived human EGFR protein
Gly696-Gly1022, with an N-terminal Met and 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

38 kDa

SDS-PAGE

39 kDa, under reducing conditions

Activity

Measured by its ability to transfer phosphate from adenosine triphosphate (ATP) to a synthetic peptide substrate.
The specific activity is >35 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human EGFR Kinase Domain His-tag Protein, CF

Recombinant Human EGFR Kinase Domain His-tag Protein SEC-MALS.

Recombinant Human EGFR Kinase Domain His-tag Protein (Catalog # 11142-ER) has a molecular weight (MW) of 37-40 kDa as analyzed by SEC-MALS, suggesting that this protein is a monomer. MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).

Recombinant Human EGFR Kinase Domain His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human EGFR Kinase Domain His-tag Protein (Catalog # 11142-ER) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 39 kDa.

Formulation, Preparation, and Storage

11142-ER
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and DTT.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: EGFR

The EGFR subfamily of receptor tyrosine kinases comprises four members: EGFR (also known as HER-1, ErbB1, or ErbB), ErbB2 (Neu, HER-2), ErbB3 (HER-3), and ErbB4 (HER-4). All family members are type I transmembrane glycoproteins with an extracellular ligand binding domain containing two cysteine-rich domains separated by a spacer region and a cytoplasmic domain containing a membrane-proximal tyrosine kinase domain followed by multiple tyrosine autophosphorylation sites (1, 2). The human EGFR cDNA encodes a 1210 amino acid (aa) precursor with a 24 aa signal peptide, a 621 aa extracellular domain (ECD), a 23 aa transmembrane segment, and a 542 aa cytoplasmic domain (3,4). The kinase domain contains the conserved catalytic domain with an ATP binding site in the cleft of two lobes at the N-terminal and C-terminal regions and an activation loop with a DFG motif that changes conformation to regulate activity (5-7). EGFR binds a subset of the EGF family ligands (1, 2) that induce EGFR homodimerization as well as heterodimerization with other family members resulting in kinase activation and cell signaling (8-10). EGFR signaling regulates multiple biological functions including cell proliferation, differentiation, motility, and apoptosis (11, 12). EGFR has been reported as overexpressed and/or mutated in tumors with high levels of activation of EGFR related to poor prognosis and tumor regression rates (13,14). EGFR kinase inhibition is a promising target for cancer therapeutics and includes development of drugs to address EGFR-mutation conferred resistance (7, 15).

References

  1. Singh, A.B. and R.C. Harris (2005) Cell. Signal. 17:1183.
  2. Shilo, B.Z. (2005) Development 132:4017.
  3. Lin, C. et al. (1984) Science 224:843.
  4. Ullrich, A. et al. (1984) Nature 309:418.
  5. Stamos, J. et. al. (2002) J. Biol. Chem. 277:46265.
  6. Liu, Q. et al. (2013) Chem. Biol. 20:146.
  7. Amelia, T. et al. (2022) Molecules 27:819.
  8. Graus-Porta, D. et al. (1997) EMBO J. 16:1647.
  9. Yarden, Y. et al. (2001) Nat. Rev. Mol. Cell Biol. 2:127. 
  10. Lemmon, M.A. (2009) Exp. Cell Res. 315:638.
  11. Sibilia, M. and E.F. Wagner (1995) Science 269:234.
  12. Miettinen, P.J. et al. (1995) Nature 376:337.
  13. Janne, P.A. et al. (2005) J. Clin. Oncol. 23:3227.
  14. Yun, C.-H. et al. (2008) Proc. Nat. Acad. Sci. USA 105:2070.
  15. Yu, J. et al. (2022) Front. Mol. Biosci. 9:847825.

Long Name

Epidermal Growth Factor Receptor

Alternate Names

EGF R, ErbB, ErbB1, HER-1

Entrez Gene IDs

1956 (Human); 13649 (Mouse); 24329 (Rat); 102138724 (Cynomolgus Monkey)

Gene Symbol

EGFR

UniProt

P00533.2

Additional EGFR Products

Product Documents for Recombinant Human EGFR Kinase Domain His-tag Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human EGFR Kinase Domain His-tag Protein, CF

For research use only

Customer Reviews for Recombinant Human EGFR Kinase Domain His-tag Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human EGFR Kinase Domain His-tag Protein, CF and earn rewards!

Have you used Recombinant Human EGFR Kinase Domain His-tag Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human EGFR Kinase Domain His-tag Protein, CF (11142-ER):

Materials
  • Assay Buffer: 50 mM Tris, 20 mM MgCl2, 5 mM MnCl2, 0.1 mg/mL BSA, pH 7.5
  • Recombinant Human EGFR (rhEGFR) (Catalog # 11142-ER)
  • Poly (4:1 Glu, Tyr), 1 mg/mL stock in 25 mM Tris, pH 7.5
  • Adenosine triphosphate (ATP), 10 mM stock in deionized water
  • ADP-GloTM Kinase Assay (Promega)
  • White 96-well Plate
  • Luminescent Plate Reader
  1. Dilute rhEGFR to 10 µg/mL in Assay Buffer.
  2. Prepare Substrate Mixture containing 65 µM ATP and 0.4 mg/mL Poly (4:1 Glu, Tyr) in Assay Buffer.
  3. Combine equal volumes of 10 µg/mL rhEGFR and Substrate Mixture. Replace enzyme with Assay Buffer for Substrate Control.
  4. Incubate at room temperature for 40 minutes.
  5. After incubation, transfer 10 µL of each reaction to a plate.
  6. Terminate the reaction and deplete the remaining ATP by adding 10 µL of ADP-GloTM Reagent to all wells.
  7. Incubate for 40 minutes at room temperature.
  8. Add 20 µL of Kinase Detection Reagent to all wells.
  9. Incubate at room temperature for 30 minutes.
  10. Read plate in Luminescence endpoint mode.
  11. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Luminescence* (RLU) x Conversion Factor** (pmol/RLU)
Incubation time (min) x amount of enzyme (µg)

    

*Adjusted for Substrate Control
**Derived using ADP-GloTM Kinase Assay Kit protocol (Promega)
Per Well:
  • rhEGFR: 0.05 µg
  • ATP: 8.125 µM
  • Poly (4:1 Glu, Tyr): 2 µg

















FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes